glp 1 oral fda approved BREAKING: The has the first GLP-1 pill for obesity, marking a major milestone in the weight-loss drug market and a potential inflection point for treatment access. The daily pill With FDA approval of Wegovy

When administered, Zepbound activates receptors in your brain that manage hunger and fullness, aiding you in feeling satiated longer and curbing cravings

In the subgroup of newer incretin-based therapies (including semaglutide and tirzepatide), the average regain rate was higher (about 1.8 pounds per month), which tracks with the fact that these drugs also produce greater initial weight loss

At the same time, type 1 diabetes is experiencing an unexplained epidemic, with its prevalence steadily rising since the 2010s

The real challenge is doing it consistently

There have been humongous barriers to access to comprehensive, evidence-based, medical obesity care, including lack of coverage for all aspects of obesity treatment, high cost of obesity medications

One notable benefit is the improvement in heart health, achieved by reducing excess weight, which in turn eases the strain on arteries and reduces stress on the heart